Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status
Sae Ishihara(Osaka City University), Masaichi Ohira(Osaka City University)
Cited by 31
Related Papers
A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study
|BMC Cancer|2018|49
Validation of Systemic and Local Tumour Immune Response to Eribulin Chemotherapy in the Treatment of Breast Cancer
|Anticancer Research|2020|18